Maryland § 13-4401

Full text of Maryland Maryland Code § 13-4401, with citation guidance and answers to common questions.

§ 13-4401.

    (a)    The Natalie M. LaPrade Medical Cannabis Commission, in consultation with the Department, the Behavioral Health Administration, the Governor’s Office of Crime Prevention and Policy, the Maryland Poison Center, the State’s designated Health Information Exchange, and the Maryland Hospital Association, shall conduct, or contract with an institution of higher education or a private research entity to conduct, a comprehensive baseline study of cannabis use in the State that includes a survey of:

        (1)    Patterns of use, including frequency of use and dosing, methods of consumption, and general perceptions of cannabis among:

            (i)    Individuals under the age of 18 years;

            (ii)    Individuals at least 18 years old and under the age of 21 years;

            (iii)    Individuals at least 21 years old and under the age of 55 years;

            (iv)    Individuals at least 55 years old;

            (v)    Pregnant women; and

            (vi)    Breastfeeding women;

        (2)    Incidents of impaired driving, including arrests, accidents, and fatalities, related to cannabis use;

        (3)    Hospitalizations related to cannabis use;

        (4)    Calls to poison control centers related to cannabis use, including data on calls related to individuals under the age of 21 years; and

        (5)    Diagnoses of cannabis use disorder and problem cannabis use.

    (b)    On or before March 1, 2023, the Natalie M. LaPrade Medical Cannabis Commission shall submit a report of the findings of the baseline study conducted under subsection (a) of this section to the Governor and, in accordance with § 2–1257 of the State Government Article, the Senate Finance Committee, the Senate Judicial Proceedings Committee, the House Judiciary Committee, and the House Health and Government Operations Committee.

    (c)    On or before March 1, 2025, and every other year thereafter, the Natalie M. LaPrade Medical Cannabis Commission shall:

        (1)    Survey the same factors that are set forth in subsection (a) of this section;

        (2)    Use the same methodology or model that is used to conduct the survey required under subsection (a) of this section; and

        (3)    Submit a report of the findings of the survey required under this subsection to the Governor and, in accordance with § 2–1257 of the State Government Article, the Senate Finance Committee, the Senate Judicial Proceedings Committee, the House Judiciary Committee, and the House Health and Government Operations Committee.

Frequently Asked Questions About Maryland § 13-4401

What does Maryland Code § 13-4401 cover?

Section 13-4401 is part of the Maryland Code, the codified statutory law of Maryland. It sets out the legal rule or procedure described in the text above. Statutes are amended regularly, so always verify against the official source.

How do I cite Maryland § 13-4401?

A common citation format is "Maryland Code § 13-4401" (Maryland). Legal writing may require the code abbreviation, section number, and year or edition. Match the style required by your court, professor, or publisher.

Is this the official text of Maryland law?

No. This page is for research and education and may not include the most recent amendments. For official current law, check the Maryland official source linked on this page or consult a licensed Maryland attorney.

How does Maryland § 13-4401 apply to my situation?

Statutes are interpreted in context, and application depends on your specific facts. Only a licensed attorney in Maryland can advise on how this section applies to you. Contact your state or local bar association for a referral.

Sources & Verification

Not legal advice. Verify against the official source and consult a licensed attorney in Maryland.